Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:658-662

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zou, L.-X.
Right arrow Articles by Navar, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, L.-X.
Right arrow Articles by Navar, L. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1996;27:658-662.)
© 1996 American Heart Association, Inc.


Articles

Renal Accumulation of Circulating Angiotensin II in Angiotensin II–Infused Rats

Li-Xian Zou; Anka Hymel; John D. Imig; L. Gabriel Navar

From the Department of Physiology, Tulane University School of Medicine, New Orleans, La.

Correspondence to Dr Li-Xian Zou, Department of Physiology, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112.

Abstract Previous studies have demonstrated that low-dose angiotensin II (Ang II) infusion for 14 days mimics two-kidney, one clip Goldblatt hypertension and increases intrarenal Ang II levels. The objective of the present study was to determine whether the augmented intrarenal Ang II is due to intrarenal accumulation of the infused Ang II and/or to an increase in intrarenal formation of endogenous Ang II. Male Sprague-Dawley rats were uninephrectomized and divided into three groups: control (n=6), those infused with [Ile5]Ang II (endogenous form) (n=6), and those infused with [Val5]Ang II (n=8). [Ile5]Ang II or [Val5]Ang II was infused at 40 ng/min via an osmotic minipump implanted subcutaneously. By day 12, systolic blood pressure increased significantly in both [Val5]Ang II–infused rats (197±7 mm Hg) and [Ile5]Ang II–infused rats (173±3 mm Hg). Blood and kidney samples were harvested, subjected to high-performance liquid chromatography to separate [Val5]Ang II from [Ile5]Ang II, and then measured by radioimmunoassay. Plasma renin activity was markedly suppressed in both [Ile5]Ang II– and [Val5]Ang II–infused rats. Plasma Ang II levels were elevated in rats infused with both [Ile5]Ang II (121±24 fmol/mL) and [Val5]Ang II (119±14 fmol/mL) compared with controls (69±15 fmol/mL). Both [Ile5]Ang II– and [Val5]Ang II–infused rats exhibited an enhancement of total intrarenal Ang II. Only [Ile5]Ang II (358±53 fmol/g) was detected in the kidneys of rats infused with [Ile5]Ang II. In [Val5]Ang II–infused rats, a significant portion of total renal Ang II (371±57 fmol/g) was in the form of [Val5]Ang II (256±44 fmol/g). Renal [Ile5]Ang II levels were maintained in the [Val5]Ang II–infused rats (116±15 fmol/g) compared with control rats (116±11 fmol/g) despite marked suppression of renin release. These results support the hypothesis that infused circulating Ang II is bound to receptor or taken up intrarenally in a manner that protects against degradation.


Key Words: angiotensin II, [Val5] • angiotensin II, [Ile5] • hypertension, renovascular • renin-angiotensin system




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Shao, D. M. Seth, and L. G. Navar
Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1067 - F1071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. R. Borges, H. C. Salgado, C. A. A. Silva, M. A. Rossi, C. M. Prado, and R. Fazan Jr.
Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1904 - R1913.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez
Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. L. Graciano, A. Nishiyama, K. Jackson, D. M. Seth, R. M. Ortiz, M. C. Prieto-Carrasquero, H. Kobori, and L. G. Navar
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F161 - F169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. M. Ortiz, M. L. Graciano, J. J. Mullins, and K. D. Mitchell
Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1584 - F1591.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Franco, F. Martinez, Y. Quiroz, O. Galicia, R. Bautista, R. J. Johnson, and B. Rodriguez-Iturbe
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R251 - R256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. M. Ortiz, M. L. Graciano, D. Seth, M. S. Awayda, and L. G. Navar
Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F139 - F147.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. L Zhuo and X. C Li
Review: Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 23 - 33.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. D Mitchell, S. J Bagatell, C. S Miller, C. R Mouton, D. M Seth, and J. J Mullins
Genetic Clamping of Renin Gene Expression Induces Hypertension and Elevation of Intrarenal Ang II Levels of Graded Severity in Cyp1a1-Ren2 Transgenic Rats
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2): 74 - 86.
[Abstract] [PDF]


Home page
HypertensionHome page
H. Kobori, A. Nishiyama, L. M. Harrison-Bernard, and L. G. Navar
Urinary Angiotensinogen as an Indicator of Intrarenal Angiotensin Status in Hypertension
Hypertension, January 1, 2003; 41(1): 42 - 49.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Ingert, M. Grima, C. Coquard, M. Barthelmebs, and J.-L. Imbs
Effects of dietary salt changes on renal renin-angiotensin system in rats
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F995 - F1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Ingert, M. Grima, C. Coquard, M. Barthelmebs, and J.-L. Imbs
Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1003 - F1010.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. FRANCO, E. TAPIA, J. SANTAMARIA, I. ZAFRA, R. GARCIA-TORRES, K. L. GORDON, H. PONS, B. RODRIGUEZ-ITURBE, R. J. JOHNSON, and J. HERRERA-ACOSTA
Renal Cortical Vasoconstriction Contributes to Development of Salt-Sensitive Hypertension after Angiotensin II Exposure
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2263 - 2271.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Kobori, L. M. Harrison-Bernard, and L. G. Navar
Enhancement of Angiotensinogen Expression in Angiotensin II-Dependent Hypertension
Hypertension, May 1, 2001; 37(5): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. KOBORI, L. M. HARRISON-BERNARD, and L. G. NAVAR
Expression of Angiotensinogen mRNA and Protein in Angiotensin II-Dependent Hypertension
J. Am. Soc. Nephrol., March 1, 2001; 12(3): 431 - 439.
[Abstract] [Full Text]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
L G. Navar, K. D Mitchell, L. M Harrison-Bernard, H. Kobori, and A. Nishiyama
Review: Intrarenal angiotensin II levels in normal and hypertensive states
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S176 - S184.
[PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Imig, G. L. Navar, L.-X. Zou, K. C. O'Reilly, P. L. Allen, J. H. Kaysen, T. G. Hammond, and L. G. Navar
Renal endosomes contain angiotensin peptides, converting enzyme, and AT1A receptors
Am J Physiol Renal Physiol, August 1, 1999; 277(2): F303 - F311.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Song and D. P. Healy
Kidney Aminopeptidase A and Hypertension, Part II : Effects of Angiotensin II
Hypertension, February 1, 1999; 33(2): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. M. Harrison-Bernard, S. S. El-Dahr, D. F. O'Leary, and L. G. Navar
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension
Hypertension, January 1, 1999; 33(1): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. G. Navar, L. Zou, A. Von Thun, C. Tarng Wang, J. D. Imig, and K. D. Mitchell
Unraveling the Mystery of Goldblatt Hypertension
Physiology, August 1, 1998; 13(4): 170 - 176.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. M.E Krekels, W. Spiering, N. C Schaper, A. J.H.M Houben, and P. W de Leeuw
Dissociation between the renal effects of angiotensin I and II in sodium-restricted normal subjects
Cardiovasc Res, April 1, 1998; 38(1): 215 - 220.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P. van Kats, L. M. de Lannoy, A. H. J. Danser, J. R. van Meegen, P. D. Verdouw, and M. A. D. H. Schalekamp
Angiotensin II Type 1 (AT1) Receptor–Mediated Accumulation of Angiotensin II in Tissues and Its Intracellular Half-life In Vivo
Hypertension, July 1, 1997; 30(1): 42 - 49.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Ichihara, E. W. Inscho, J. D. Imig, R. E. Michel, and L. G. Navar
Role of Renal Nerves in Afferent Arteriolar Reactivity in Angiotensin-Induced Hypertension
Hypertension, January 1, 1997; 29(1): 442 - 449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Harrison-Bernard, J. Zhuo, H. Kobori, M. Ohishi, and L. G. Navar
Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F19 - F25.
[Abstract] [Full Text] [PDF]